Sellas Life Sciences Group Inc (SLS)

Dec 10, 2025

Why SELLAS Life Sciences Group (SLS) Is Up 12.6% After Encouraging SLS009 Phase 2 AML Data And What's Next - Yahoo Finance

Dec 10, 2025

Dec 09, 2025

Sellas Life Sciences draws retail buzz on SLS009 trial momentum – stock soars in pre-market - MSN

Dec 09, 2025

Dec 09, 2025

SELLAS Life Sciences Draws Retail Buzz On SLS009 Trial Momentum – Stock Soars In Pre-Market - Stocktwits

Dec 09, 2025

Dec 08, 2025

SELLAS Life Sciences: Clinical Trials Ignite Stock Interest - timothysykes.com

Dec 08, 2025

Dec 08, 2025

Sellas Life Sciences rises after reporting encouraging AML clinical results - MSN

Dec 08, 2025

Dec 08, 2025

Sellas Life Sciences stock jumps after promising AML treatment data By Investing.com - Investing.com UK

Dec 08, 2025

Dec 08, 2025

Sellas Life Sciences stock jumps after promising AML treatment data - Investing.com

Dec 08, 2025

Dec 08, 2025

SELLAS Rises On Positive Phase 2 Data Of SLS009 In Relapsed/Refractory AML-MR - Nasdaq

Dec 08, 2025

Dec 08, 2025

Sellas Life Says Phase 2 Study of Cancer Combination Treatment Shows 'Clinically Meaningful' Activity; Shares Up Pre-Bell - marketscreener.com

Dec 08, 2025

Dec 07, 2025

SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025 - The Manila Times

Dec 07, 2025

Dec 07, 2025

SELLAS Life Sciences (NASDAQ: SLS) reports 58% response, 8.9-month OS in AML study - Stock Titan

Dec 07, 2025

Dec 06, 2025

Trend Recap: Is SELLAS Life Sciences Group Inc RXK3 stock cheap by valuation metricsJuly 2025 Snapshot & Capital Efficiency Focused Ideas - moha.gov.vn

Dec 06, 2025

Dec 06, 2025

Should You Track Refex Industries Limited as a LongTerm Growth Play - earlytimes.in

Dec 06, 2025

Dec 04, 2025

Sellas Life Sciences Progress Sparks Optimism in Market - StocksToTrade

Dec 04, 2025

Dec 04, 2025

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - KamloopsBCNow

Dec 04, 2025

Dec 04, 2025

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - Benzinga

Dec 04, 2025

Dec 04, 2025

SELLAS Life Sciences Gains Momentum with Impressive Phase 2 Data and Financial Strength - timothysykes.com

Dec 04, 2025

Dec 03, 2025

How institutional buying supports SELLAS Life Sciences Group Inc. stockShare Buyback & High Accuracy Trade Alerts - Newser

Dec 03, 2025

Dec 03, 2025

How SELLAS Life Sciences Group Inc. (RXK3) stock compares with top peersQuarterly Profit Review & Stock Portfolio Risk Control - Newser

Dec 03, 2025

Dec 02, 2025

Is SELLAS Life Sciences Group Inc. (RXK3) stock cheap by valuation metrics2025 Investor Takeaways & Long-Term Safe Investment Plans - Newser

Dec 02, 2025

Dec 02, 2025

Is SELLAS Life Sciences Group Inc. (RXK3) stock a contrarian opportunityBreakout Watch & Weekly Chart Analysis and Guides - Newser

Dec 02, 2025

Nov 28, 2025

SELLAS Life Sciences Group Inc RXK3 Stock Analysis and ForecastStock Split Announcements & Technical + Fundamental = Smarter Investing - earlytimes.in

Nov 28, 2025

Nov 26, 2025

[EFFECT] SELLAS Life Sciences Group, Inc. SEC Filing - Stock Titan

Nov 26, 2025

Nov 24, 2025

SELLAS Advances AML Pipeline With GPS And SLS009 - RTTNews

Nov 24, 2025

Nov 22, 2025

Katherine Bach Kalin Acquires 63,400 Shares of SELLAS Life Sciences Group (NASDAQ:SLS) Stock - MarketBeat

Nov 22, 2025

Nov 21, 2025

Katherine Kalin Increases Stake in SELLAS Life Sciences Group Inc - GuruFocus

Nov 21, 2025

Nov 21, 2025

Kalin Katherine Bach buys SELLAS Life Sciences (SLS) shares By Investing.com - Investing.com Nigeria

Nov 21, 2025

Nov 21, 2025

Kalin Katherine Bach buys SELLAS Life Sciences (SLS) shares - Investing.com

Nov 21, 2025

Nov 21, 2025

[Form 4] SELLAS Life Sciences Group, Inc. Insider Trading Activity - Stock Titan

Nov 21, 2025

Nov 20, 2025

Analyzing SELLAS Life Sciences Group Inc. with risk reward ratio chartsWeekly Gains Report & Precise Swing Trade Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

How SELLAS Life Sciences Group Inc. stock valuations compare to rivals2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com

Nov 20, 2025

Nov 19, 2025

Does SELLAS Life Sciences Group Inc. show high probability of rebound - newser.com

Nov 19, 2025

Nov 19, 2025

SELLAS Life Sciences Group Sees Unusually Large Options Volume (NASDAQ:SLS) - MarketBeat

Nov 19, 2025

Nov 19, 2025

How risky is SELLAS Life Sciences Group Inc. stock nowPortfolio Performance Report & AI Forecast Swing Trade Picks - newser.com

Nov 19, 2025

Nov 19, 2025

Can SELLAS Life Sciences Group Inc. (RXK3) stock hold up in economic slowdown2025 Earnings Impact & Short-Term Trading Opportunity Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

SELLAS Life Sciences Group Inc. stock prediction for this weekWeekly Investment Recap & Weekly Breakout Stock Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Why millennials buy SELLAS Life Sciences Group Inc. (RXK3) stock2025 Growth vs Value & Daily Momentum Trading Reports - newser.com

Nov 19, 2025

Nov 19, 2025

SELLAS Life Sciences Group Inc. stock trend forecastWeekly Trade Analysis & Verified Trade Idea Suggestions - newser.com

Nov 19, 2025

Nov 19, 2025

Is SELLAS Life Sciences Group Inc. showing signs of accumulationWeekly Trend Report & Entry and Exit Point Strategies - newser.com

Nov 19, 2025

Nov 18, 2025

Is SELLAS Life Sciences Group Inc. reversing from oversold territory2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - newser.com

Nov 18, 2025